During the past decade, University Cancer Center at University of Washington Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 55 clinical trials were completed, i.e. on average, 5500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Cancer Center at University of Washington Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 82 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Cancer Center at University of Washington Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 122 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University Cancer Center at University of Washington Medical Center" are "Breast Cancer" (22 trials), "Lung Cancer" (19 trials), "Lymphoma" (17 trials), "Prostate Cancer" (12 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "University Cancer Center at University of Washington Medical Center" in a lesser frequency.

Most popular intervention types in "University Cancer Center at University of Washington Medical Center" are "Drug" (96 trials), "Radiation" (36 trials), "Biological" (35 trials), "Procedure" (28 trials) and "Other" (24 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (19 trials), "cyclophosphamide" (18 trials), "cisplatin" (12 trials), "doxorubicin hydrochloride" (12 trials) and "paclitaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "University Cancer Center at University of Washington Medical Center" are 97 trials for "All" genders, 23 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "University Cancer Center at University of Washington Medical Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 107 completed trials in University Cancer Center at University of Washington Medical Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in University Cancer Center at University of Washington Medical Center, 8 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".